[1]
Marta, G.N. et al. 2019. ANALYSIS OF CLINICAL OUTCOMES BASED ON MOLECULAR SUBTYPES IN PATIENTS WITH BREAST CANCER THAT RECEIVED NEOADJUVANT CHEMOTHERAPY. Mastology. 29, 3 (Sep. 2019), 4. DOI:https://doi.org/10.29289/259453942019v29s1g03.